首页 > 市场调查报告书 > 医疗设备

生技设备

寡核苷酸合成市场规模、份额及成长分析（依产品、产品类型、应用、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900131

寡核苷酸合成市场规模、份额及成长分析（依产品、产品类型、应用、最终用户及地区划分）－2026-2033年产业预测

Oligonucleotide Synthesis Market Size, Share, and Growth Analysis, By Product (Oligonucleotide, Reagents), By Type (Custom Oligos, Predesigned Oligos), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球寡核苷酸合成市场规模预计在 2024 年达到 73 亿美元，从 2025 年的 85.7 亿美元成长到 2033 年的 309.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 17.4%。

全球慢性病发生率的上升趋势，以及对医疗研发的大量投入，正在推动寡核苷酸合成的需求。精准医疗和个人化医疗的日益普及有望为合成服务提供者创造新的商机。此外，基因疗法在多种疾病治疗中的应用日益广泛，以及寡核苷酸在医疗领域的应用不断拓展，也将进一步推动这些公司的市场发展。合成技术的进步以及人们对核酸疗法的日益关注，预计也将促进市场成长。北美地区由于医疗研发投入庞大，已成为主要市场之一，但高昂的合成成本、复杂的法规结构、伦理问题以及有限的生产能力等挑战可能会抑制市场需求。

全球寡核苷酸合成市场驱动因素

寡核苷酸是多种诊断技术（包括PCR、qPCR和次世代定序(NGS)）的关键组成部分，显着推动了对早期诊断解决方案的需求。随着医疗保健领域对快速准确诊断的日益重视，高品质寡核苷酸的需求预计将大幅增长。这种对早期检测的日益关注将为寡核苷酸合成市场带来新的成长机会，为技术进步和产能提升创造条件。因此，调查方法的不断发展进一步凸显了寡核苷酸合成在满足全球人口日益增长的医疗需求方面的重要性。

限制全球寡核苷酸合成市场的因素

全球寡核苷酸合成市场面临的主要限制因素是寡核苷酸的高生产成本，尤其是那些对治疗应用至关重要的高纯度或复杂结构的寡核苷酸。此外，纯化过程和严格的品管措施也增加了整体财务负担。这种经济壁垒使得小规模的生技公司难以投资必要的资源并在市场中有效竞争。因此，财务限制抑制了寡核苷酸合成领域的创新和成长机会，进而影响了整个市场的扩张。

全球寡核苷酸合成市场趋势

全球寡核苷酸合成市场正经历着向人工智慧 (AI) 和自动化融合的动态转变，这显着改变了合成流程。这一趋势提高了寡核苷酸生产的准确性和扩充性，从而实现了更精准、更有效率的生产。自动化合成仪和 AI 驱动的设计工具不仅提高了营运效率，还有助于大幅降低成本，使高品质寡核苷酸更容易获得。随着研究需求的成长以及基因组学和个人化医疗等领域应用的不断扩展，这些先进技术的应用预计将加速发展，从而推动产业创新和竞争优势的形成。因此，在这些技术进步的驱动下，市场可望强劲成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Agilent Technologies（USA）
LGC Biosearch Technologies（UK）
Integrated DNA Technologies（IDT）（USA）
Eurofins Genomics（Luxembourg）
GenScript Biotech Corporation（USA）
Twist Bioscience（USA）
Bio-Synthesis Inc.（USA）
ATUM（USA）
DNA Script（France）
SGI-DNA（USA）
Eurogentec（Kaneka）（Belgium）
Creative Biogene（USA）
GeneCust Europe（Luxembourg）
Synbio Technologies（USA）
Epoch Life Science, Inc.（USA）
Bioneer Corporation（South Korea）
Genewiz（Azenta Life Sciences）（USA）

结论与建议

简介目录

Product Code: SQMIG35H2107

Global Oligonucleotide Synthesis Market size was valued at USD 7.30 Billion in 2024 and is poised to grow from USD 8.57 Billion in 2025 to USD 30.93 Billion by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The growing incidence of chronic diseases globally, coupled with significant investments in medical research and development, is driving the demand for oligonucleotide synthesis. The surge in popularity of precision and personalized medicine is expected to present new business opportunities for synthesis providers. Additionally, the increasing acceptance of gene therapies for various conditions and the expanding applications of oligonucleotides across healthcare sectors will further enhance opportunities for these companies. Advancements in synthesis technologies and a rising focus on nucleic acid-based therapeutics are also projected to contribute to market growth. North America stands out as a leading market due to substantial healthcare research spending, though challenges such as high synthesis costs, complex regulatory frameworks, ethical concerns, and limited manufacturing capacities could hinder demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oligonucleotide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segments Analysis

Global Oligonucleotide Synthesis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Oligonucleotide, Reagents and Equipment. Based on Type, the market is segmented into Custom Oligos and Predesigned Oligos. Based on Application, the market is segmented into Therapeutic Applications, Diagnostics, Research and Others. Based on End User, the market is segmented into Academic Research Institutes, Pharmaceutical and Biotechnology Companies,, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oligonucleotide Synthesis Market

Oligonucleotides are essential components in various diagnostic technologies like PCR, qPCR, and next-generation sequencing (NGS), driving a significant demand for early diagnostic solutions. As the healthcare landscape increasingly prioritizes swift and accurate diagnostics, the need for high-quality oligonucleotides is expected to surge. This growing emphasis on early detection is likely to unlock new avenues for growth within the oligonucleotide synthesis market, presenting opportunities for advancements in technology and increased production capabilities. Consequently, the ongoing evolution of diagnostic methodologies further underscores the importance of oligonucleotide synthesis in meeting the rising healthcare needs of the global population.

Restraints in the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market faces constraints primarily due to the high costs associated with producing oligonucleotides, particularly those with high purity or complex structures essential for therapeutic use. Additionally, the expenses related to purification processes and rigorous quality control measures contribute to the overall financial strain. This economic barrier results in limited accessibility for smaller biotechnology companies, which may struggle to invest in the necessary resources to compete effectively in the market. Consequently, the financial limitations hinder innovation and growth opportunities within the oligonucleotide synthesis sector, affecting the overall expansion of the market.

Market Trends of the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market is experiencing a dynamic shift towards the integration of artificial intelligence and automation, significantly transforming synthesis processes. This trend enhances the accuracy and scalability of oligonucleotide production, enabling more precise and efficient manufacturing. Automated synthesizers and AI-driven design tools not only streamline operations but also contribute to substantial cost reductions, making high-quality oligonucleotides more accessible. As research demands grow and applications in genomics and personalized medicine expand, the adoption of these advanced technologies is expected to accelerate, driving innovation and competitive advantage within the sector. Consequently, the market is poised for robust growth propelled by these technological advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Oligonucleotide Synthesis Market Size by Product & CAGR (2026-2033)

Market Overview
Oligonucleotide
- DNA
- Column-based
- Array-based
- RNA
- Technology
- Column-based
- Array-based
- Type
- Short RNA Oligos (< 65 nt)
- Long RNA Oligos (> 65 nt)
- CRISPR (sgRNA)
Reagents
Equipment

Global Oligonucleotide Synthesis Market Size by Type & CAGR (2026-2033)

Market Overview
Custom Oligos
Predesigned Oligos

Global Oligonucleotide Synthesis Market Size by Application & CAGR (2026-2033)

Market Overview
Therapeutic Applications
Diagnostics
Research
Others

Global Oligonucleotide Synthesis Market Size by End User & CAGR (2026-2033)

Market Overview
Academic Research Institutes
Pharmaceutical and Biotechnology Companies,
Diagnostic Laboratories
Others

Global Oligonucleotide Synthesis Market Size & CAGR (2026-2033)

North America (Product, Type, Application, End User)
- US
- Canada
Europe (Product, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (IDT) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Synthesis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATUM (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNA Script (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGI-DNA (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurogentec (Kaneka) (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCust Europe (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbio Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epoch Life Science, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (Azenta Life Sciences) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments